Cargando…

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease—A Pediatric Perspective

Cardiovascular diseases (CVD) are a hallmark in pediatric patients with chronic kidney disease (CKD) contributing to an enhanced risk of all-cause and CV morbidity and mortality in these patients. The bone-derived phosphaturic hormone fibroblast growth factor (FGF) 23 progressively rises with declin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grund, Andrea, Sinha, Manish D., Haffner, Dieter, Leifheit-Nestler, Maren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372151/ https://www.ncbi.nlm.nih.gov/pubmed/34422725 http://dx.doi.org/10.3389/fped.2021.702719

Ejemplares similares

Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice
por: Leifheit-Nestler, Maren, et al.
Publicado: (2021)

Cardiac FGF23 expression correlates with left ventricular hypertrophy in patients with chronic kidney disease
por: Leifheit-Nestler, Maren, et al.
Publicado: (2014)

Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
por: Eitner, Fiona, et al.
Publicado: (2022)

How FGF23 shapes multiple organs in chronic kidney disease
por: Leifheit-Nestler, Maren, et al.
Publicado: (2021)

Renal effects of growth hormone in health and in kidney disease
por: Haffner, Dieter, et al.
Publicado: (2021)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

FGF23 and Phosphate–Cardiovascular Toxins in CKD
por: Vogt, Isabel, et al.
Publicado: (2019)

Editorial: Mineral and Bone Disorder in CKD
por: Printza, Nikoleta, et al.
Publicado: (2022)

Rickets guidance: part II—management
por: Haffner, Dieter, et al.
Publicado: (2022)

Rickets guidance: part I—diagnostic workup
por: Haffner, Dieter, et al.
Publicado: (2021)

FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
por: Böckmann, Ineke, et al.
Publicado: (2019)

Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review
por: Woroniecki, Robert P., et al.
Publicado: (2017)

Commentary: Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review
por: Perez Fernandez, Guillermo A.
Publicado: (2017)

The Correlation Between ABPM Parameters and Left Ventricular Hypertrophy in Pediatric Essential Hypertension
por: Wu, Haojie, et al.
Publicado: (2022)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Association between red blood cell distribution width and left ventricular hypertrophy in pediatric essential hypertension
por: Sun, Xiaodong, et al.
Publicado: (2023)

Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts
por: Haffner, Dieter, et al.
Publicado: (2022)

Strategies for Optimizing Growth in Children With Chronic Kidney Disease
por: Haffner, Dieter
Publicado: (2020)

Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension
por: Lin, Yao, et al.
Publicado: (2019)

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
por: Grabner, Alexander, et al.
Publicado: (2017)

Comparison of two echocardiography-based methods for evaluating pediatric left ventricular diastolic dysfunction
por: Xiang, Xue, et al.
Publicado: (2023)

Higher Serum Lysophosphatidic Acids Predict Left Ventricular Reverse Remodeling in Pediatric Dilated Cardiomyopathy
por: Wen, Haichu, et al.
Publicado: (2021)

Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity
por: Leifheit-Nestler, Maren, et al.
Publicado: (2013)

Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy
por: Schultze-Berndt, Alina, et al.
Publicado: (2021)

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
por: Dussold, Corey, et al.
Publicado: (2019)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Eosinophils Are More Strongly Relevant to Allergic Sensitization Than Basophils in Pediatric Adenotonsillar Hypertrophy
por: Zou, Juanjuan, et al.
Publicado: (2021)

Analysis of factors that influence the occurrence of otitis media with effusion in pediatric patients with adenoid hypertrophy
por: Chen, Wenjing, et al.
Publicado: (2023)

Left ventricular hypertrophy among chronic kidney disease patients in Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2017)

Impact of Overhydration on Left Ventricular Hypertrophy in Patients With Chronic Kidney Disease
por: Sun, Lianqin, et al.
Publicado: (2022)

OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2020)

Myocardial Energetics in Left Ventricular Hypertrophy
por: Jameel, Mohammad N, et al.
Publicado: (2009)

Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass
por: Maanja, Maren, et al.
Publicado: (2017)

The Correlation Between Otitis Media With Effusion and Adenoid Hypertrophy Among Pediatric ‎Patients: A Systematic Review‎
por: Mashat, Ghadi D, et al.
Publicado: (2022)

Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers
por: Bacharova, Ljuba, et al.
Publicado: (2023)

Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia
por: Isa Tafreshi, Roya, et al.
Publicado: (2022)

Advances in symptomatic therapy for left ventricular non-compaction in children
por: Li, Dong, et al.
Publicado: (2023)

Albuminuria Is Associated with Left Ventricular Hypertrophy in Patients with Early Diabetic Kidney Disease
por: Wu, Nan, et al.
Publicado: (2014)

Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease
por: Drożdż, Dorota, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n7fcm27lh0kb0dmllhmahfrnds